Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 43, Issue 3, 1997, Pages 287-294

  Blanco, M D ^a   Alonso, M J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Biodegradable nanospheres; Multiple emulsion; Poly(lactide co glycolide); Protein delivery; Protein stability

Indexed keywords

NANOPARTICLE; POLOXAMER; POLYGLACTIN; SOLVENT;

ARTICLE; DRUG RELEASE; ENCAPSULATION; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN SECRETION; PROTEIN STABILITY;

EID: 0031395214     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00056-8     Document Type: Article

References (19)

1. S.P. Swendeman, Stability of proteins and their delivery from biodegradable polymer microspheres, in: Cohen, S. and Bernstein, H. (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-51.
2. T. Kissel, R. Koneberg, Injectable biodegradable microspheres for vaccine delivery, in: Cohen, S. and Bernstein, H. (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 51-89.
3. A.J. Almeida, H.O. Alpar, R.W. Brown, Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea pigs, J. Pharm. Pharmacol., 45 (1993) 198-203.
4. D.T. O'Hagan, J.P. McGee, J.P. Boyle, D. Gumaer, X.M. Li, B. Potts, C.Y. Wang, W.C. and Koff, The preparation, characterization and pre-clinical evaluation of an orally administered HIV-1 vaccine consisting of a branched peptide immunogen entrapped in controlled release microparticles, J. Control. Release, 36 (1995) 75-84.
5. D.T. O'Hagan, J.P. McGee, M. Lindblad, J. Holmgren, Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization. Int. J. Pharm., 119 (1995) 251-255.
6. J. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley, T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target to the Peyer's patches. J. Control. Release, 11 (1990) 205-214.
7. T.H. Ermak, E.P. Bougherty, H.R. Bhagat, Z. Kabok, J. Pappo. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells, Cell. Tissue Res., 279 (1995) 433-436.
8. P. Jani, G.W. Halbert, J. Langridge, A.T. Florence, The uptake and translocation of latex nanospheres and microspheres after oral administration to rats, J. Pharm. Pharmacol., 41 (1989) 808-812.
9. P. Jani, W. Gavin, G.W. Halbert, J. Langridge, A.T. Florence, Nanoparticulate uptake by the rat gastrointestinal mucosa: quantification and particle size dependency, J. Pharm. Pharmacol., 24 (1990), 821-826.
10. P. Jani, D.E. McCarthy, A.T. Florence, Nanospheres and microspheres uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm., 86 (1992) 239-246.
11. P.G. Jenkins, K.A. Howard, N.M. Blackball, N.W. Thomas, S.S. Davis, D.T. O'Hagan, Microparticulate absorption from the rat intestine, J. Control. Release, 29 (1994) 339-350.
12. M.J. Alonso, Nanoparticulate drug carrier technology, in: Cohen, S. and Bernstein, H. (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 203-243.
13. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice, R.M. Gilley, M.E. Hudson, Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm. Res., 7 (1990) 1190-1194.
14. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, R. Langer. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res., 8 (1991) 713-720.
15. D.T. O'Hagan, H. Jeffery, S.S. Davis, The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vivo release of a model protein. Int. J. Pharm., 103 (1994) 37-45.
16. H. Sah, R. Toddywala, Y.W. Chien, Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant. J Control. Release, 35 (1995) 137-144.
17. M.J. Alonso, S. Cohen, T.W. Park, R.K. Gupta, G. Siber, R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res., 10 (1993) 945-953.
18. M.J. Alonso, M.M. Gaspar, D. Blanco, M.E.M. Cruz, Development of polylactic/glycolic acid nanospheres containing a high loading of L-asparaginase. Proc. Int. Symp. Control. Release Bioact. Mater., 23 (1996) 831-832.
19. I. Esparza, T. Kissel, Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine, 10 (1992) 714-720.